Nalbuphine is effective in decreasing the rewarding effect induced by morphine in rats

Drug and Alcohol Dependence

Volumn 84, Issue 2, 2006, Pages 175-181

  Tao, Pao Luh ^a   Liang, Kai Wen ^a   Sung, Wen Yi ^a   Wu, Yung Tsun ^a   Huang, Eagle Yi Kung ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Conditioned place preference; Locomotor activity; Mesolimbic pathway; Microdialysis; Morphine; Nalbuphine; Nucleus accumbens

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE DERIVATIVE; HOMOVANILLIC ACID; MORPHINE; NALBUPHINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; LIMBIC CORTEX; LOCOMOTION; MALE; MICRODIALYSIS; MORPHINE ADDICTION; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONDITIONING (PSYCHOLOGY); DRUG TOLERANCE; HOMOVANILLIC ACID; LOCOMOTION; MALE; MORPHINE; NALBUPHINE; NARCOTIC ANTAGONISTS; NARCOTICS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; REWARD;

EID: 33746555442     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.01.013     Document Type: Article

References (36)

1. Bonci A., Bernardi G., Grillner P., and Mercuri N.B. The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction. Trends Pharmacol. Sci. 24 (2003) 172-177
2. Cameron D.L., Wessendorf M.W., and Williams J.T. A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience 77 (1997) 155-166
3. Ciccocioppo R. The role of serotonin in craving: from basic research to human studies. Alcohol 34 (1999) 244-253
4. David H.N., Ansseau M., and Abraini J.H. Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals. Brain Res. Rev. 50 (2005) 336-360
5. Di Chiara G., Bassareo V., Fenu S., Luca M.A.D., Spina L., Cadoni C., Acquas E., Carboni E., Valentini V., and Lecca D. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 (2004) 227-241
6. Emmerson P.J., Clark M.J., Mansour A., Akil H., Woods J.H., and Medzihradsky F. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. J. Pharmacol. Exp. Ther. 278 (1996) 1121-1127
7. Errick J.K., and Heel R.C. Nalbuphine: a preliminary review of its pharmacological properties and therapeutic efficacy. Drugs 26 (1983) 191-211
8. Funada M., Suzuki T., Narita M., Misawa M., and Nagase H. Blockade of morphine reward through the activation of κ-opioid receptors in mice. Neuropharmacology 32 (1993) 1315-1323
9. Gear R.W., Miaskowski C., Gordon N.C., Paul S.M., Heller P.H., and Levine J.D. The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain 83 (1999) 339-345
10. Hasebe K., Kawai K., Suzuki T., Kawamura K., Tanaka T., Narita M., Nagase H., and Suzuki T. Possible pharmacotherapy of the opioid κ receptor agonist for drug dependence. Ann. N. Y. Acad. Sci. 1025 (2004) 404-413
11. Hoskin P.J., and Hanks G.W. Opioid agonist-antagonist drugs in acute and chronic pain states. Drugs 41 (1991) 326-344
12. Huang E.Y.K., Liu T.C., and Tao P.L. Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens. Naunyn Schmiedebergs Arch. Pharmacol. 368 (2003) 386-392
13. Kuzmin A.V., Semenova S., Gerrits M.A., Zvartau E.E., and Van Ree J.M. κ-Opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur. J. Pharmacol. 321 (1997) 265-271
14. Kuzmin A.V., Gerrits M.A., Zvartau E.E., and Van Ree J.M. Influence of buprenorphine, butorphanol and nalbuphine on the initiation of intravenous cocaine self-administration in drug naïve mice. Eur. Neuropsychopharmacol. 10 (2000) 447-454
15. Lee S.C., Wang J.J., Ho S.T., and Tao P.L. Nalbuphine coadministered with morphine prevents tolerance and dependence. Anesth. Analg. 84 (1997) 810-815
16. Margolis E.B., Hjelmstad G.O., Bonci A., and Fields H.L. κ-Opioid agonists directly inhibit midbrain dopaminergic neurons. J. Neurosci. 23 (2003) 9981-9986
17. Margolis E.B., Hjelmstad G.O., Bonci A., and Fields H.L. Both kappa and mu agonists inhibit glutamatergic input to ventral tegmental area neurons. J. Neurophysiol. 93 (2005) 3086-3093
18. Marinelli M., Moal M.L., and Piazza P.V. Sensitization to the motor effects of contingent infusions of heroin but not of κ agonist RU 51599. Psychopharmacology 139 (1998) 281-285
19. Narita M., Funada M., and Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol. Ther. 89 (2001) 1-15
20. Narita M., Kishimoto Y., Ise Y., Yajima Y., Misawa K., and Suzuki T. Direct evidence for the involvement of the mesolimbic κ-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state. Neuropsychopharmacology 30 (2005) 111-118
21. Paxinos G., and Watson C. The Rat Atlas in Stereotaxic Coordinates. third ed. (1996), Academic Press, New York
22. Pchelintsev M.V., Gorbacheva E.N., and Zvartau E.E. Simple methodology of assessment of analgesics' addictive potential in mice. Pharmacol. Biochem. Behav. 39 (1991) 873-876
23. Preston K.L., and Jasinski D.R. Abuse liability studies of opioid agonist-antagonists in humans. Drug Alcohol Depend. 28 (1991) 49-82
24. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18 (1993) 247-291
25. Schmidt W.K., Tam S.W., Shotzberger G.S., Smith Jr. D.H., Clark R., and Vernier V.G. Nalbuphine. Drug Alcohol Depend. 14 (1985) 339-362
26. Self D.W. Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 47 (2004) 242-255
27. 35S]GTPγS binding in mMOR-CHO cells and rat thalamus. J. Pharmacol. Exp. Ther. 285 (1998) 496-505
28. Shippenberg T.S., Chefer V.I., Zapata A., and Heidbreder C.A. Modulation of the behavioral and neurochemical effects of psychostimulants by κ-opioid receptor systems. Ann. N. Y. Acad. Sci. 937 (2001) 50-73
29. Smith M.A., Chisholm K.A., Bryant P.A., Greene J.L., McClean J.M., Stoops W.W., and Yancey D.L. Social and environmental influences on opioid sensitivity in rats: importance of an opioid's relative efficacy at the mu-receptor. Psychopharmacology 181 (2005) 27-37
30. Souza E.B.D., Schmidt W.K., and Kuhar M.J. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. J. Pharmacol. Exp. Ther. 244 (1988) 391-402
31. Spanagel R., Herz A., and Shippenberg T. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 2046-2050
32. Stevenson G.W., Folk J.E., Linsenmayer D.C., Rice K.C., and Negus S.S. Opioid interactions in rhesus monkeys: effects of δ + μ and δ + κ agonists on schedule-controlled responding and thermal nociception. J. Pharmacol. Exp. Ther. 307 (2003) 1054-1064
33. Traynor J.R., Clark M.J., and Remmers A.E. Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists. J. Pharmacol. Exp. Ther. 300 (2002) 157-161
34. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56 (1998) 613-672
35. Wang J.J., Ho S.T., and Hu O.Y.P. Comparison of intravenous nalbuphine infusion versus saline as an adjuvant for epidural morphine. Reg. Anesth. 21 (1996) 214-218
36. Wang J.J., Ho S.T., and Tzeng J.I. Comparison of intravenous nalbuphine infusion versus naloxone in the prevention of epidural morphine-related side effects. Reg. Anesth. Pain Med. 23 (1998) 479-484